C000253453 Fees and Costs — LifeX 2056 Inflation-Protected Longevity Income ETF

Data updated: 2025-08-29

The net expense ratio is 0.25%. There are no sales loads or redemption fees. Portfolio turnover was 419%.

C000253453 Fees and Expenses

Annual operating expenses and sales charges of C000253453. Prospectus, as of April 30, 2025.

Annual operating expenses
Management fee0.25%
12b-1 fee0.00%
Other expenses0.00%
Gross expense ratio0.25%
Fee waiver—
Net expense ratio0.25%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

C000253453 Costs Over Time

On $10,000 invested in C000253453, assuming 5% a year before costs, total costs come to $159 over 5 years, cutting the return by 0.26% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.25%)$26$83$144
Lost growth on money paid in costs$0$4$14
Total costs$26$87$159
Value after costs$10,474$11,490$12,604
Impact on return, per year0.26%0.26%0.26%

C000253453 Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2024.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $22.1M
  • Portfolio turnover (prospectus): 419%
  • Securities lending: none during the year

C000253453 Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
CITADEL SECURITIES LLC$8.2M37.18%
MORGAN STANLEY & CO. LLC$6.0M26.98%
BOFA SECURITIES INC.$3.5M16.01%
J.P. MORGAN SECURITIES LLC$2.5M11.52%
GOLDMAN SACHS & CO. LLC$1.8M8.30%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.